[Treatment of anemia in pregnant women by a complex method with application of carbostimulin]
Related Experiment Video
Updated: Aug 16, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Abstract:
The medicinal effect of carbostimulin was studied under conditions of anemia in pregnant women. A group of pregnant women (n-54) who were given carbostimulin in addition to the ordinary antianemic therapy showed a 2.5-fold increase of erythrocytes and 1.6-fold rise of hemoglobin as compared to the control group. The number of labour complications decreased: a 5-fold decrease was observed for the intrauterine hypoxia of the fetus and the amount of delayed labour. The percentage of labour with surgical intervention lowered from 40.0 down to 18.5. The frequency of the instrumental examination of the womb cavity and digital removal of the placenta were 6 and 3.4 times as low, respectively. The number of children of small weight became more than twice as low (from 27 up to 12.2%). There were less newborns in the state of light and heavy asphyxia (1.5 and 3.7 times, respectively). No cases of perinatal mortality were observed. Parameters of the newborns peripheral blood improved.

